Gi-Won Choi
Director de Operaciones en QURIENT CO., LTD. .
Fortuna: 19 325 $ al 31/05/2024
Origen de la red de primer grado Gi-Won Choi.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Gi-Won Choi a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Seoul National University | College/University | Graduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
BNP Paribas Securities Korea Co., Ltd.
 BNP Paribas Securities Korea Co., Ltd. Financial ConglomeratesFinance BNP Paribas Securities Korea Co., Ltd. is the Korea-based broker/dealer subsidiary of BNP Paribas SA (EPA: BNP) in France. Headquartered in Seoul, the firm was founded in 2002 and provides financial investment services for Local and Foreign Institutional Investors, Corporates, and Financial Institutions. | Financial Conglomerates | Director of Research - Equity | |
BNP Paribas Securities (Asia) Ltd.
 BNP Paribas Securities (Asia) Ltd. Investment Banks/BrokersFinance BNP Paribas Securities (Asia) Ltd. (BNPP SEC ASIA) is the Hong Kong-based brokerage subsidiary of BNP Paribas SA (EPA: BNP), an international banking group headquartered in France. BNPP SEC ASIA provides electronic trading services to its clients, including its affiliates which take principal or riskless principal positons. Such services enable the access to, and execution of trades via, alternative liquidity pools (ALPs), or commonly known as dark pools, operated by other service providers or affiliates of the firm (Third Party ALPs). | Investment Banks/Brokers | Analyst-Equity | |
Institut Pasteur Korea Research Foundation
 Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Biotechnology | Investor Relations Contact | |
| The State University of New York | College/University | Doctorate Degree | |
SamKyeong Accounting Co.
 SamKyeong Accounting Co. Miscellaneous Commercial ServicesCommercial Services SamKyeong Accounting Co. provides accounting services. The company was founded in 1986 and is headquartered in Seoul, South Korea. | Miscellaneous Commercial Services | Director/Board Member | |
| University of London | College/University | Doctorate Degree | |
| Korea University | College/University | Undergraduate Degree | |
| Gachon University | College/University | Corporate Officer/Principal |
Estadísticas
Internacional
| Corea del Sur | 7 |
| Francia | 2 |
| Hong-Kong | 2 |
| Estados Unidos | 2 |
| Reino Unido | 2 |
Sectorial
| Consumer Services | 7 |
| Finance | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 5 |
| Doctorate Degree | 4 |
| Undergraduate Degree | 3 |
| Analyst-Equity | 2 |
| Corporate Officer/Principal | 2 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Tae-Sik Park | 4 |
| Peter Yu | 3 |
| Jae-Seung Kim | 3 |
| Yoon-Su Kang | 3 |
| Young-Mi Ji | 3 |
| Ki-Yean Nam | 2 |
- Bolsa de valores
- Insiders
- Gi-Won Choi
- Conexiones Empresas
